QuantHealth has raised $45 million in a Series B funding [...]

Circio is preparing to advance its circular RNA gene therapy [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]

Verdiva Bio has dosed the first patient in a Phase [...]

Medicus Pharma has received FDA clearance to begin a Phase [...]

CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]

Adneuris Therapeutics has granted Zhejiang Conba Pharmaceutical exclusive rights to [...]

Alto Neuroscience has raised $100 million through an underwritten registered [...]

A peer-reviewed study published in Therapeutic Innovation & Regulatory Science [...]

Gesynta Pharma has randomised half of the planned patients in [...]